genome analysis
Sophia Genetics Q2 Revenue Grows 72 Percent
In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO.
Sema4, Avera Health Collaborate on Precision Oncology Program
The partnership, which will start with oncology, will introduce Sema4's genomic testing and Centrellis health intelligence technology to Avera's clinical and research programs.
The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery.
Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships
The stock opened at $18 per share, valuing the Switzerland- and Boston-based bioinformatics company at $1.14 billion.
Sophia Genetics Increases IPO Target to $221M
The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million.
Jun 8, 2021
May 6, 2021
NantHealth Q1 Revenues Decline 11 Percent
Apr 12, 2021
Mar 17, 2021
Mar 2, 2021
Genomics Plc Closes $30M Funding Round
Feb 25, 2021
NantHealth Q4 Revenues Flat From Year Ago
Feb 19, 2021